
    
      Patients who have been diagnosed with breast cancer and have undergone Guardant360 testing
      will be approached regarding participation in the study. After being informed about the study
      and potential risks, all patients providing informed consent and access to their medical
      records, will provide a list of their health care providers related to their cancer
      treatment. Data related to their routine clinical care will be abstracted from medical
      records.
    
  